3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Phase 1/2
1
Phase 1
1
Status
Unknown
1
Sponsor Class
OTHER_GOV
1
Study Type
Interventional
1
Sponsor
Cancer Type
CNS
1
Conditions
Polycystic Ovary Syndrome
8
Neoplasm Metastasis
5
Breast Neoplasms
5
Neoplasms
3
Recurrence
2
Prostatic Neoplasms
2
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Pancreatic Neoplasms
2
Obesity
2
Multiple Myeloma
2
Metabolic Diseases
2
Leukemia, Lymphocytic, Chronic, B-Cell
2
Insulin Resistance
2
Infertility
2
Glioblastoma
2
Carcinoma, Ovarian Epithelial
2
Brain Neoplasms
2
Weight Loss
1
Waldenstrom Macroglobulinemia
1
Thrombocytopenia
1
TP53 Y220C Mutation
1
Splenomegaly
1
Solid Tumor, Adult
1
Small Cell Lung Carcinoma
1
Sezary Syndrome
1
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
1
Pancreatic Adenocarcinoma
1
Ovarian Neoplasms
1
Mycosis Fungoides
1
Mouth Neoplasms
1
Interventions
Temozolomide
41
Radiotherapy
15
Magnetic Resonance Spectroscopy
12
Surgical Procedures, Operative
10
Bevacizumab
10
Irinotecan
9
Radiation
8
Nivolumab
7
Carmustine
7
Specimen Handling
6
Radiosurgery
6
Carboplatin
6
ribociclib
5
O(6)-benzylguanine
5
Imiquimod
5
IL13-PE38
5
Flucytosine
5
Filgrastim
5
Erlotinib Hydrochloride
5
Cyclophosphamide
5
Aminolevulinic Acid
5
vandetanib
4
sargramostim
4
Topotecan
4
Lomustine
4
Imatinib Mesylate
4
Etoposide
4
Craniotomy
4
vocimagene amiretrorepvec
3
temsirolimus
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 1
×
Glioma
×
Metformin
×
Clear all
NCT02149459
2017-10-27
SMC 0712-13
Sheba Medical Center
Phase 1
Unknown
18 enrolled